374 related articles for article (PubMed ID: 15256312)
1. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes.
Wiviott SD; de Lemos JA; Morrow DA
Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.
de Lemos JA; Morrow DA; Bentley JH; Omland T; Sabatine MS; McCabe CH; Hall C; Cannon CP; Braunwald E
N Engl J Med; 2001 Oct; 345(14):1014-21. PubMed ID: 11586953
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
[TBL] [Abstract][Full Text] [Related]
4. [Brain natriuretic peptide in acute coronary syndromes: utility of NT-pro BNP assay].
Ollivier JP; Revel F
Bull Acad Natl Med; 2004; 188(9):1529-38; discussion 1538-40. PubMed ID: 15997622
[TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides for risk stratification of patients with acute coronary syndromes.
Galvani M; Ferrini D; Ottani F
Eur J Heart Fail; 2004 Mar; 6(3):327-33. PubMed ID: 14987584
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of N-terminal proB-type natriuretic peptide.
Costello-Boerrigter LC; Burnett JC
Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):194-201. PubMed ID: 16265483
[TBL] [Abstract][Full Text] [Related]
8. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain.
Kwan G; Isakson SR; Beede J; Clopton P; Maisel AS; Fitzgerald RL
J Am Coll Cardiol; 2007 Mar; 49(11):1186-92. PubMed ID: 17367663
[TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide as an integrated risk marker in non-ST elevation acute coronary syndromes.
Yamamoto T; Sato N; Yasutake M; Takagi H; Morita N; Akutsu K; Fujii M; Fujita N; Tanaka K; Takano T
Int J Cardiol; 2006 Aug; 111(2):224-30. PubMed ID: 16185779
[TBL] [Abstract][Full Text] [Related]
10. The clinical role of natriuretic peptides--importance of BNP and NT-proBNP. Implications in heart failure and acute coronary syndrome.
Machado M; Falcão LM; Ravara L
Rev Port Cardiol; 2004; 23(7-8):1005-32. PubMed ID: 15478326
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
Windhausen F; Hirsch A; Sanders GT; Cornel J; Fischer J; van Straalen JP; Tijssen JG; Verheugt FW; de Winter RJ;
Am Heart J; 2007 Apr; 153(4):485-92. PubMed ID: 17383283
[TBL] [Abstract][Full Text] [Related]
12. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
[TBL] [Abstract][Full Text] [Related]
14. [Atrial natriuretic peptides: a new diagnostic tool for the internist].
Boari B; Manfredini R; Fellin R
Recenti Prog Med; 2005 Jun; 96(6):300-10. PubMed ID: 16078761
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of B-type natriuretic Peptide in patients with unstable angina pectoris or acute myocardial infarction: prognostic significance and therapeutic implications.
Ahmed W; Zafar S; Alam AY; Ahktar N; Shah MA; Alpert MA
Angiology; 2007; 58(3):269-74. PubMed ID: 17626979
[TBL] [Abstract][Full Text] [Related]
16. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
[TBL] [Abstract][Full Text] [Related]
17. Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes.
de Lemos JA; Morrow DA
Rev Cardiovasc Med; 2003; 4 Suppl 4():S37-46. PubMed ID: 14564227
[TBL] [Abstract][Full Text] [Related]
18. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
[TBL] [Abstract][Full Text] [Related]
19. Natriuretic peptides in unstable coronary artery disease.
Jernberg T; James S; Lindahl B; Johnston N; Stridsberg M; Venge P; Wallentin L
Eur Heart J; 2004 Sep; 25(17):1486-93. PubMed ID: 15342167
[TBL] [Abstract][Full Text] [Related]
20. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
O'Donoghue M; de Lemos JA; Morrow DA; Murphy SA; Buros JL; Cannon CP; Sabatine MS
Circulation; 2006 Aug; 114(6):550-7. PubMed ID: 16880323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
